Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum

被引:32
作者
Boon, A. C. [1 ]
Hawkins, C. L. [2 ,3 ]
Coombes, J. S. [4 ]
Wagner, K. H. [5 ]
Bulmer, A. C. [1 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld 4222, Australia
[2] Heart Res Inst, Sydney, NSW 2042, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[4] Univ Queensland, Sch Human Movement Studies, St Lucia, Qld 4072, Australia
[5] Univ Vienna, Dept Nutr Sci, A-1090 Vienna, Austria
关键词
Bile pigments; Heme oxygenase; Antioxidants; Protein oxidation; Myeloperoxidase; Chloramines; Free radicals; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC LESIONS; NITROGEN-CENTERED RADICALS; HYPOCHLORITE-MODIFIED PROTEINS; ALBUMIN-BOUND BILIRUBIN; CARDIOVASCULAR-DISEASE; GILBERTS-SYNDROME; HEART-DISEASE; LIPID-PEROXIDATION;
D O I
10.1016/j.freeradbiomed.2015.05.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Hypochlorous acid (HOCl), an oxidant produced by myeloperoxidase (MPO), induces protein and lipid oxidation, which is implicated in the pathogenesis of atherosclerosis. Individuals with mildly elevated bilirubin concentrations (i.e., Gilbert syndrome; GS) arc protected from atherosclerosis, cardiovascular disease, and related mortality. We aimed to investigate whether exogenous/endogenous unconjugated bilirubin (UCB), at physiological concentrations, can protect proteins/lipids from oxidation induced by reagent and enzymatically generated HOCl. Serum/plasma samples supplemented with exogenous UCB (<= 250 mu M) were assessed for their susceptibility to HOCl and MPO/H2O2/Cl- oxidation, by measuring chloramine, protein carbonyl, and malondialdehyde (MDA) formation. Serum/plasma samples from hyperbilirubinemic Gunn rats and humans with GS were also exposed to MPO/H2O2/Cl- to: (1) validate in vitro data and (2) determine the relevance of endogenously elevated UCB in preventing protein and lipid oxidation. Exogenous UCB dose dependently (P<0.05) inhibited HOCl and H2O2/Cl--induced chloramine formation. Albumin bound UCB efficiently and specifically (3.9-125 mu M; P<0.05) scavenged taurine, glycine, and N-alpha-acetyllysine chloramines. These results were translated into Gunn rat and GS serum/plasma, which showed significantly (P<0.01) reduced chloramine formation after MPO-induced oxidation. Protein carbonyl and MDA formation was also reduced after MPO oxidation in plasma supplemented with UCB (P<0.05; 25 and 50 mu M, respectively). Significant inhibition of protein and lipid oxidation was demonstrated within the physiological range of UCB, providing a hypothetical link to protection from atherosclerosis in hyperbilirubinemic individuals. These data demonstrate a novel and physiologically relevant mechanism whereby UCB could inhibit protein and lipid modification by quenching chloramines induced by MPO-induced HOCl. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 66 条
[1]
Usefulness of Serum Bilirubin and Cardiorespiratory Fitness as Predictors of Mortality in Men [J].
Ajja, Rahma ;
Lee, Duck-chul ;
Sui, Xuemei ;
Church, Timothy S. ;
Steven, N. Blair .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10) :1438-1442
[2]
The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[3]
Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations [J].
Boon, Ai-Ching ;
Bulmer, Andrew C. ;
Coombes, Jeff S. ;
Fassett, Robert G. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (02) :F123-F136
[4]
Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome [J].
Boon, Ai-Ching ;
Hawkins, Clare L. ;
Bisht, Kavita ;
Coombes, Jeff S. ;
Bakrania, Bhavisha ;
Wagner, Karl-Heinz ;
Bulmer, Andrew C. .
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (10) :2120-2127
[5]
Bilirubin and beyond: A review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection [J].
Bulmer, A. C. ;
Verkade, H. J. ;
Wagner, K. -H. .
PROGRESS IN LIPID RESEARCH, 2013, 52 (02) :193-205
[6]
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration [J].
Bulmer, A. C. ;
Coombes, J. S. ;
Blanchfield, J. T. ;
Toth, I. ;
Fassett, R. G. ;
Taylor, S. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (07) :1857-1870
[7]
Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection [J].
Bulmer, Andrew C. ;
Blanchfield, Joanne T. ;
Toth, Istvan ;
Fassett, Robert G. ;
Coornbes, Jeff S. .
ATHEROSCLEROSIS, 2008, 199 (02) :390-396
[8]
Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P15
[9]
Serum Bilirubin Links UGT1A1*28 Polymorphism and Predicts Long-Term Cardiovascular Events and Mortality in Chronic Hemodialysis Patients [J].
Chen, Ying-Hwa ;
Hung, Szu-Chun ;
Tarng, Der-Cherng .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (03) :567-574
[10]
Chevion M, 2000, FREE RADICAL RES, V33, pS99